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Abstract
Background: It is well considered that reactive oxygen species (ROS) plays a prominent causative role in the
development of allergic rhinitis (AR), and eosinophils cells as important allergic inflammatory cells contribute to
elevating oxidative stress. Hydrogen, emerging as a novel antioxidant, has been proven effective in selectively
reducing ROS in animals models of oxidative damage. We herein aim to verify protective effects of hydrogen on
eosinophils cells in guinea pigs models of AR.
Methods: Thirty two guinea pigs were random divided into four groups, and AR model was established through
ovalbumin sensitization. The guinea pigs were injected with hydrogen-rich saline (Normal-HRS and AR-HRS group)
or normal saline (control and AR group). The frequencies of sneezing and scratching were recorded. The IgE level,
blood eosinophil count and eosinophil cationic protein (ECP) level in serum were measured. The serum malondialdehyde
(MDA) and superoxide dismutase (SOD) assays were also measured to evaluate oxidative stress. The expression levels of
eotaxin mRNA and protein in the nasal mucosa were also determined by real-time RT-PCR, Western blot and
immunofluorescence.
Results: HRS reduced the ROS and MDA levels and increased SOD level in guinea pigs of AR-HRS group
accompanied with decreased frequency of sneezing and scratches. Meanwhile, there was a decline of the
number of eosinophils cells in blood and of thelevel of ECP in serum in the AR-HRS group. HRS also significantly decreased
the expression of eotaxin in nasal mucosa.
Conclusion: HRS may play a protective role in attenuating allergic inflammation, and suppressing the increase
and activation of eosinophils in AR possibly through antioxidation effect of hydrogen.
Keywords: Allergic rhinitis, Reactive oxygen species, Hydrogen-rich saline, Eosinophil, Eosinophil cationic protein, Eotaxin,
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Background
Rhinitis, especially allergic rhinitis (AR), is a major
health problem. Although several treatments such as
corticosteroid and anti-histamine drugs are available for
dealing with it, their side effects have limited the use of
them. Recent studies have shown that oxidative stress
and the production of reactive oxygen species (ROS)
contribute to allergic inflammation, such as asthma and
AR. The main sources of ROS are NAD (P) H oxidase,
xanthine oxidase, lipoxygenase, mitochondria, and the
uncoupling nitric oxide synthase [1]. It has been re-
ported that the oxidation ability is significantly increased
in patients with atopic asthma and AR compared to
healthy individuals [2].
Many observations suggest that oxidative stress plays
an important role in the pathogenesis of airway allergic
inflammation such as asthma and AR [3]. As important
pathogenic factors of AR, ROS can increase mucosa per-
meability and mucus production accompanied with in-
flux of inflammatory cells, decrease numbers and
function of epithelial cilia, and alter expression of adhe-
sion molecules and release of inflammatory mediators. A
growing number of reports havedemonstrated that
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oxidative stress and its resultant production of ROS play
prominent roles in the mechanism of inflammatory
responses during asthma and AR [4–6].
Airway and circulating inflammatory cells and espe-
cially eosinophils are the likely source of ROS increases.
For instance, antigen challenge increases spontaneous
ROS from airway eosinophils in patients with asthma
[7], and some research shows that blood eosinophils also
produces more ROS in asthmatic patients compared
with control subjects [8]. The eosinophils isolated from
allergic patients also produces more hydrogen peroxides
when challenged with antigen [9]. Thus eosinophils cells
as important allergic inflammatory cells contribute to
elevated oxidative stress in allergic disease.
Recently, it has been proved that hydrogen gas, a
highly flammable gas, has potent antioxidant property.
Compared with other antioxidants gas such as carbon
monoxide (CO) and Hydrogen sulfide (H2S), hydrogen
could selectively reduce the hydroxyl radical (∙OH) and
peroxynitriteanion (ONOO-), the most cytotoxic chemi-
cals of ROS, and effectively protect cells; in addition,
hydrogen does not react with other ROS, which
possesses physiological roles [10]. Since the hydrogen
molecule is electrically neutral and much smaller than
the other antioxidants, it is able to easily penetrate
membranes and enter cells and organelles, such as the
nucleus and mitochondria, where most commonly used
antioxidants cannot arrive [11]. However, hydrogen gas
inhalation as a clinical application is not convenient and
may be dangerous because it is inflammable and com-
bustible. Compared with hydrogen gas, hydrogen satu-
rated in saline (i.e., a hydrogen-rich saline, HRS) is safe
and easy to administer. It has been demonstrated that
treatment with HRS protects organs damage from oxida-
tion effect in animals models such as transient cerebral
ischemia [12], neonatal cerebral hypoxia–ischemia [13],
renal injury [14] and myocardial injury induced by ische-
mia and reperfusion [15]. Although some study shows
that HRS as an interesting anti-allergic treatment could
alleviate respiratory symptom of asthma [16], no researches
focus on the effect of treatment with hydrogen on AR, so
we make the present study to explore whether HRS could,
in its potential as an antioxidant for preventive and thera-
peutic applications in AR, attenuate eosinophil activation
through guinea pigs models.
Methods
Material and animal models
HRS was generously offered by Professor Li Bailong
(the Second Military Medical University, Shanghai,
China) and prepared as described previously [17]. In
short, hydrogen gas (0.4 mPa) was dissolved in nor-
mal saline for at least 2 h to reach supersaturated
level (>0.6 mmol/L).
Mature healthy male guinea pigs weighing ±230 g
were purchased from National Rodent Laboratory
Animal Resources (Shanghai, China). All animal care
and experimental procedures were approved by the
Tongji University Institution Animal Care and Use
Committee (2014-DW-009).
The AR models were prepared as follows. 32 guinea
pigs were randomly divided into four groups (n = 8 each
group), namely, Control groups, normal-HRS, AR-NS
and AR-HRS. The AR-NS and AR-HRS groups were
both sensitized with ovalbumin (OVA, Sigma Corporation,
USA). Each guinea pig was first sensitized intraperitone-
ally with 0.3 mg of OVA and 30 mg of Aluminum hydrox-
ide (AL (OH) 3) every other day for a total of seven times.
From day 15 on, the guinea pigs were treated with 0.5%
OVA aerosol to stimulate AR symptoms for five times.
Subsequently, each side of the nasal cavity was given
20 μL of 2% OVA solution intranasally once a day to
maintain AR symptoms. The control group and normal-
HRS groups were health guinea pigs who are given the
same dose of saline treatment.
From day 20 on, the guinea pigs of the AR-HRS group
and Normal-HRS group were intraperitoneally injected
with a dose of 10 mL/kg HRS and intranasally with
20 μL of HRS on each side once a day. The guinea pigs
in the AR-NS group and control group were also given
the same dose of saline both intraperitoneally and intra-
nasally every day. The treatment continued for 14 days.
Observation of frequencies of scratching and sneezing
The frequencies of scratching and sneezing were
assessed for 1 h directly after nasal challenge. Sneezing
was characterized by an explosive expiration just after
deep inspiration. Scratching was characterized by an
external perinasal scratch with the animal’s forelimbs.
Determination of total IgE and eosinophil cationic protein
(ECP) level in serum
The guinea pigs were anesthetized by intraperitoneal
administration of pentobarbital (40 mg/kg). These ani-
mals were sacrificed by rapid decapitation, and then
blood and nasal mucosa were collected. Biopsies of the
nasal mucosa were taken from the inferior turbinate and
immediately placed in liquid nitrogen. Peripheral blood
was collected and the separated serum was kept at − 20 °C.
Serum total IgE (R&D Corporation,USA) and ECP (R&D
Corporation, USA) were determined by enzyme-linked im-
munosorbent assay method (CAP system). The detectable
range of the assay for total IgE is 2–200 ng/mL, and for
serum ECP is 2 to 100 ng/L.
Blood eosinophil count
A peripheral venous blood sample was collected and
eosinophils were counted through automatic blood cell
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analyzer (Sysmex Medical Electronics Co. Ltd. Japan).
The detectable range of blood eosinophil counted in the
same way is 0 to 10,000/μL.
Determination of ROS in serum and nasal mucosa
The levels of serum ROS were measured with highly
sensitive enzyme-linked immunosorbent assay (ELISA)
kits according to the manufacturer’s recommendations
(Shanghai Tongwei Co., Ltd, China). The absorbance
(OD) was measured at 450 nm wavelength with the
enzyme marker, and the ROS concentration in the sam-
ple was calculated by standard curve. The detectable
range of the assay is 10 IU/ml -320 IU/ml.
ROS levels in nasal mucosa were measured with 2,7-
dichlorofuorescin diacetate (DCFH-DA). Collected nasal
mucosa were incubated with DCFH-DA for 30 min at
37 °C. DCFH-DA forms a fluorescent product, DCF
(dichloro fluorescein) upon oxidation with ROS.
Fluorescence caused by DCF in each well was mea-
sured and recorded for 30 min at 500 nm (excitation)
and 530 nm (emission).
Serum malondialdehyde (MDA) and superoxide dismutase
(SOD) assays
To further confirm that HRS-induced inhibition of
inflammation was related to the anti-oxidative property
of HRS, the oxidative stress markers were measured with
MDA and SOD. SOD is endogenous antioxidants as free
radical scavenger, and MDA is the lipid per oxidation
end product.
Serum MDA levels were measured with a commercial
MDA assay kit (Nanjing Jiancheng Bioengineering Insti-
tute, Nanjing, China). Briefly, hydroxytoluene combined
with thiobarbituric acid was able to become red. The ab-
sorbance of condensation products was tested at a
wavelength of 532 nm. The levels of MDA in nasal mu-
cosa tissue were normalized against total protein (mg
protein/mL). The activity of SOD was measured with a
commercial assay kit (Nanjing Jiancheng Bioengineering
Institute, Nanjing, China), in accordance with the manu-
facturer’s instructions. Briefly, this assay kit uses a thia-
zole salt for detection of superoxide anions to produce a
colored product; absorbance was tested at a wavelength
of 450 nm.
RNA isolation and real-time RT-PCR for eotaxin
Fluorescent quantitative real time RT–PCR was per-
formed to determine the expression levels of eotaxin
mRNAs in nasal mucosa. The total RNA was extracted
and cDNA was synthesized with a cDNA synthesis kit
(Prime Script RTase, TaKaRa Inc., Japan). To determine
the expression of eotaxin, we performed a fluorescent
quantitative real-time RT–PCR assay. Primer sequences
used are listed in Table 1; mRNA levels were normalized
relative to GAPDH mRNA levels.
Western blot analyses of eotaxin
The guinea pig nasal mucosa (10 mg), which was frozen
in liquid nitrogen, was homogenized in 1 mL of protein
lysis buffer (PBS containing 0.1% Triton X-100) and cen-
trifuged at 14,000 g for 10 min at 4 °C. Nasal mucosa
lysates from each group were analyzed by Western blot.
Table 1 Examined genes and their PCR primers
Gene Primer sequence 5′→ 3′ Amplification
size (bp)
eotaxin-1 F:5′-AACCCAGAAACTATTGTCACGCT-3′
R:5′-GGACATTTGCTGCTGGTGATTAT-3′
216
GAPDH F:5′-AAAGGCATCTTGGGCTACACC-3′
R:5′-GCTGTAGCCGAACTCATTGTCATA-3′
153
Fig. 1 Frequency of scratching and sneezing of guinea pigs. For the four groups: saline control, normal-HRS, AR- NS and AR-HRS. Each column
and vertical bar represents the mean ± S.D. *,**: Significantly different from the control group (p < 0.05 and p < 0.01, respectively). #,## Significantly
different from the AR-NS group (p < 0.05 and p < 0.01, respectively)
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The blots were blocked with PBS-T containing 1% skim
milk and then incubated with a 1:1000 dilution of anti-
eotaxin antibody (Beyotime biotechnology, China) at
room temperature. After three additional washes, the
blots were incubated with anti-mouse secondary
antibody (1:5000) (Beyotime biotechnology, China) and
then conjugated to horseradish peroxidase for 1 h at
room temperature. The second batch of images was
quantified using Quantity One software (Bio-Rad
Laboratories, USA). GAPDH was employed as an
Fig. 2 IgE level in serum of guinea pigs. For the four groups: saline control, normal-HRS, AR- NS and AR-HRS. Each column and vertical bar represents
the mean ± S.D. *, **: Significantly different from the control group (p < 0.05 and p < 0.01, respectively). #, ## Significantly different from the AR-NS group
(p < 0.05 and p < 0.01, respectively)
Fig. 3 Levels of ROS in serum and nasal mucosa of groups. For the four groups: saline control, normal-HRS, AR- NS and AR-HRS. Levels of ROS in
serum (a) and nasal mucosa (b) were shown. Each column and vertical bar represents the mean ± S.D. *,**: Significantly different from the control
group (p < 0.05 and p < 0.01, respectively). #,## Significantly different from the AR-NS group (p < 0.05 and p < 0.01, respectively)
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endogenous control for protein normalization. The ex-
periments were performed in duplicate.
Immunofluorescence of eotaxin in nasal mucosa
Tissues from the specimens were fixed in 10% buffered
formalin. Immunohistochemical stains were performed
on formalin-fixed and paraffin-embedded 4 μm sections.
The tissue sections were deparaffined, and permeabilized
in precooled acetone at − 20 °C for 15 min. Slides were
washed in PBS. Normal goat serum (10% in PBS) was
used to block nonspecific antibody binding. The slides
were incubated for 1 h at room temperature with anti–
Eotaxin-1 rat monoclonal antibody (1:100, Boster Co.
Ltd. China). Slides were washed twice in PBS, and then
incubated for 30 min at room temperature with anti-rat
Cy3-conjugated IgG (1:50, Boster Co. Ltd. China). Slides
were washed twice in PBS and once in distilled water
and allowed to dry. Fluorescence microscope was applied
to observation and photograph.
Statistical analysis
Statistical analyses were performed using SPSS version
17.0 (SPSS Inc., Chicago, Illinois, USA). All data were
expressed as mean ± S.D. Statistical analyses of data were
performed using ANOVA for multiple comparison and
Least Significant Difference (LSD) for comparison among
groups, and Pearson Correlation for the two-variable
correlation analysis. p < 0.05 was considered statisti-
cally significant.
Results
Frequencies of scratching and sneezing and IgE level in
serum
The frequencies of scratching and sneezing are shown in
Fig. 1. The frequencies of scratching and sneezing in the
AR-sensitized group were significantly increased com-
pared with the control group (p < 0.05), and no signifi-
cant changes were found in normal guinea pigs after
HRS treatment (p > 0.05). In the AR-HRS group, the
frequencies of scratching and sneezing decreased sig-
nificantly compared with those of the AR-NS group
(p < 0.05). It indicates that inflammatory symptom of
AR was alleviated by HRS in guinea pigs.
The level of IgE of groups is shown in Fig. 2. In the
AR-NS group it is higher than that in the control group
(175.44 ± 10.02 ng/mL vs.65.24 ± 8.44 ng/mL, p < 0.01).
After HRS treatment, the IgE content in the AR-HRS
guinea pigs is significantly decreased (92.70 ± 7.66 ng/
mL vs 175.44 ± 10.02 ng/mL, p < 0.05). Otherwise, there
is no significant difference between control and Normal-
HRS group (68.76 ± 10.45 g/mL vs.65.24 ± 8.44 ng/mL,
p > 0.05). All these results indicate that HRS could
reduce the inflammatory response of AR accompanied
with decreased IgE level.
HRS treatment reduced oxidative stress
Enhanced oxidative stress was observed in AR animals,
as evidenced with the elevated ROS levels of serum and
nasal mucosa (Fig. 3a and b), and the elevation appeared
Fig. 4 Levels of MDA and SOD in serum of groups. For the four groups: saline control, normal-HRS, AR- NS and AR-HRS. Levels of MDA (a) and
SOD (b) in serum were shown. Each column and vertical bar represents the mean ± S.D. *,**: Significantly different from the control group (p < 0.05
and p < 0.01, respectively). #,## Significantly different from the AR-NS group (p < 0.05 and p < 0.01, respectively)
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to be significantly inhibited by HRS treatment (p < 0.05).
Moreover, decreased changes for SOD activity and in-
creased MDA levels in serum were observed (Fig. 4a
and b), and after HRS treatment, elevated ROS was
inhibited by HRS accompanied with increased SOD
level and decreased MDA level significantly (p < 0.05).
Similarly, no significant difference between control
and Normal-HRS group was found (p > 0.05). The
correlation between the makers was also carried out,
and there was a highly significant correlation between
ROS and MDA levels (r = 0.87, P < 0.01) (Fig. 5a), sug-
gesting that levels of MDA were positively correlated
with ROS. Otherwise, there was also a highly
significant correlation between ROS and SOD levels
(r = 0.64, P < 0.01) (Fig. 5b), suggesting that levels of
SOD were negatively correlated with ROS. All this
suggests that HRS treatment could reduce oxidative
stress of AR significantly.
Blood eosinophil count and ECP concentrations in serum
Similarly, eosinophil count in AR group was signifi-
cantly higher than in control group. ((0.41 ± 0.06) ×
109/L vs.(0.26 ± 0.03) × 109/L, p < 0.05) and decreased
significantly with HRS treatment ((0.31 ± 0.04) × 109/L,
p < 0.05) (Fig. 6a). Otherwise, no significant difference
was also found between control group and normal-
HRS groups ((0.32 ± 0.03) × 109/L vs. (0.26 ± 0.03) ×
109/L, p > 0.05).
Serum ECP level was 741.98 ± 69.7 pg/mL in AR group
was significantly higher than that of control subjects
(533.13 ± 39.14 pg/mL, p < 0.05), while it was 554.48 ±
36.53 pg/mL in AR-HRS group and 512.39 ± 32.478 in
normal-HRS group (Fig. 6b). There was a significantly dif-
ference between AR-HRS and AR-NS groups (p < 0.01).
Also, serum ECP was correlated with blood eosinophil
count (r = 0.65, p < 0.01) (Fig. 7a), and serum total IgE
(r = 0.56, p < 0.01) significantly (Fig. 7b).
Fig. 5 Correlation analysis of serum ROS, MDA and SOD. Serum ROS was correlated with MDA levels (r = 0.87, P < 0.01) (a), and SOD levels
(r = 0.64, P < 0.01) (b)
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Reduction of eotaxin mRNA and protein expression in nasal
mucosa by HRS treatment
The eotaxin mRNA and protein expression in the nasal mu-
cosa of the AR sensitized significantly grew up (p < 0.05).
Similarly, no significant difference between control and
Normal-HRS group was found (p > 0.05). However,
the mRNA and protein expression of eotaxin in the
HRS-treated group decreased significantly compared
with that of the AR-NS group (p < 0.05 for each
(Figs. 8 and 9). These results indicate that HRS could
suppress the eotaxin expression in allergic inflamma-
tion conditions.
Assessing eotaxin expression by immunofluorescence
Histology seems to confirm the above findings. Figure 10c
shows plenty of eotaxin in the cell nucleus of nasal
mucosa taken from AR and NS group, while in control
subjects and normal-HRS subjects eosinophil infiltration
is very scarce (Fig. 10a and b). Otherwise, the eotaxin of
the HRS-treated group is relatively low expression
(Fig. 10d). All this indicates that HRS could reduce
eotaxin expression in the nasal mucosa of AR.
Discussion and conclusions
Our results have demonstrated that HRS, functioning as
a scavenger of ROS, could have the anti-allergic inflam-
mation therapeutic value in AR disease. ROS are classic-
ally defined as partially reduced metabolites of oxygen
that possess strong oxidizing capabilities. They contain
∙OH, O2, H2O2, ONOO, NO−, are important cytotoxic
molecules and signal mediators in the pathophysiological
mechanisms of inflammatory diseases [18, 19]. Among
them, ∙OH and ONOO− are much more reactive than
others and are regarded as major cytotoxic mediators of
cellular oxidative damage [20].
Under physiological condition, tissues contain various en-
dogenous antioxidant enzymes like GSH and SOD, which
scavenge ROS and prevent lipid peroxidation, and maintain
the relevant balance [21]. In the process of AR, the antigens
have been shown to induce human nasal epithelial cells to
produce ROS that trigger cytokine production in AR, and
ROS were overproduced and then induced an imbalance
between the ROS and endogenous antioxidants or antioxi-
dant enzymes. The overproduced ROS were able to directly
or indirectly damage the nasal mucosa, which results in
mucosa dysfunction and histological changes [22].
Fig. 6 Blood eosinophil count and ECP concentrations in serum of groups. For the four groups: saline control, normal-HRS, AR- NS and AR-HRS.
Blood eosinophil count and ECP concentrations in serum of groups were shown. Each column and vertical bar represents the mean ± S.D. *,**:
Significantly different from the control group (p < 0.05 and p < 0.01, respectively). #,## Significantly different from the AR-NS group (p < 0.05 and
p < 0.01, respectively)
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In 2007, researchers from Japan reported that hydro-
gen gas possessing antioxidant and anti-apoptotic
properties could protect the brain against ischemia-
reperfusion injury and stroke by selectively reducing
hydroxyl radicals · OH and ONOO-in cell-free systems.
Indeed, more researches have been reported that hydro-
gen reacts only with the strongest oxidants (∙OH and
ONOO−) and does not disrupt metabolic redox reac-
tions or ROS concerned in cell signaling [23]. It is dem-
onstrated that HRS has an essential role in ROS
clearance. In vitro study, the researchers demonstrated
that hydrogen showed promising efficacy in many dis-
ease models [24, 25]. A growing number of reports have
demonstrated that oxidative stress and its resultant pro-
duction of ROS play prominent roles in the mechanism
of inflammatory responses as asthma, renal injury, etc.
In the process of inflammation, ROS are overproduced
and then induce an imbalance between the ROS and
endogenous antioxidants or antioxidant enzymes, and
HRS can neutralize the ROS and eases the oxidative
damage in inflammation such as asthma and pancreatitis
[16, 26]. However, there are no reports of HRS in
research of AR disease, although HRS may also exert
anti-inflammatory effects in rhinitis.
In order to observe the antioxidation effect of HRS in
AR, levels of MDA and SOD in serum were observed in
this experiment. MDA can be used as a crosslinking
agent to promote the cross-linking of nucleic acids, pro-
teins and phospholipids, and to change the function of
biological macromolecules. The content of MDA can
reflect the degree of lipid per oxidation. SOD, as dispro-
portionation of superoxide anion generation of H2O2,
can scavenge ROS, prevent lipid per oxidation, and pro-
tect cells from damaging of toxic oxygen radicals. There-
fore, SOD is an important enzyme in the defense of the
superoxidion from the body or external environment.
The increase of MDA levels and decrease of SOD activ-
ity can lead to oxidative stress reaction, which will result
in cell damage and even cell death. It is showed that in
the process of allergen-induced airway inflammation, the
inflammatory mediators can stimulate eosinophils to
produce ROS that can be inhibited by SOD [27]. In this
study, upregulated oxidative metabolism in allergic
models compared to those from normal subjects was
Fig. 7 Correlation analysis of serum ECP, eosinophil count and serum total IgE. Pearson Correlation was used to analyze the relationship. Serum
ECP was correlated with blood eosinophil count (r =0.65, p < 0.01) (a), and serum total IgE (r = 0.56, p < 0.01) significantly (b)
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shown, and ROS levels in AR animal appeared to be re-
duced by HRS accompanied with increased SOD level
and decreased MDA level. These results indicate that
HRS neutralizes the ROS and eases the oxidative damage
from allergic inflammation. After HRS treatment, the
AR guinea pigs showed relieved symptoms of allergic
reaction, such as nasal scratching nose and sneezing.
The observations indicate that HRS exerts potent anti
oxidative and anti-inflammatory effects, and it can
attenuate the severity of AR in guinea pigs.
In order to investigate the influence of HRS on inflam-
mation of AR, the function and counts of eosinophils
were also studied, because abnormalities of quantity and
activity of eosinophils are typical features of AR. The
present observations indicate that the declined number
of eosinophils may be associated with drug-induced
eosinophil apoptosis of tissue. It has been widely as-
sumed that apoptosis of eosinophils of airway tissue
would be increased by treatment such as corticosteroid,
and inducement of eosinophil apoptosis has thus been
advocated as a major pharmacological mechanism to
bring about resolution of allergic inflammation [28, 29].
However, more studies are needed to confirm the induc-
tion of apoptotic eosinophils with HRS.
It has been known that ECP is released by activated
eosinophils, and ROS with activated eosinophils affect
the ECP levels [30]. Our study had shown that eosino-
phils concentration and ECP levels in serum is increased
in guinea pigs with AR, and the ECP levels in AR animal
appeared to be reduced by HRS accompanied with de-
creased eosinophils concentration in serum. The ECP
levels in the serum could reflect the rate of activation of
circulating eosinophils [31]. Indeed, the serum levels of
ECP in allergic asthma and atopic dermatitis are signifi-
cantly higher [32]. Since ECP may be a major cause of
chronic airway inflammation, it may also be an objective
parameter of inflammation in respiratory allergic dis-
eases. It is strongly involved in upper and lower airway
inflammation, such as AR, nasal polyps and widely used
as a standard marker of eosinophil activity [33]. ECP
levels, correlated well with the number of eosinophils,
could be useful in evaluating the degree of inflammation
in patients with AR, and as an effective clinical test for
evaluating the effectiveness of allergic inflammation
therapy [34], for eg. pollen specific immunotherapy [35].
In our research, the therapy with HRS in AR can influ-
ence serum ECP levels, which indicates that HRS can
suppress active eosinophil in AR.
Moreover, it is reported that eotaxin has a greater
effect on priming eosinophil ROS, and eotaxin plays an
important role in the pathogenesis of allergic inflamma-
tion through eosinophil activation by priming the
Fig. 8 Expression of eotaxin mRNA in nasal mucosa. Sizes of PCR products are 216 bp (eotaxin) and 153 bp (GAPDH). Lanes from left to right
were products of saline control, normal-HRS, AR-NS and AR-HRS. There was an increase in eotaxin mRNA in AR-NS group compared with control,
and eotaxin decrease dafter HRS treated (*p < 0.05 versus control, #p < 0.05 versus AR-NS), whereas there was no change in GAPDH mRNA. No
significance of mRNA expression were shown between control and Normal-NS groups (*p > 0.05)
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Fig. 10 Immuno cytochemistry of Eotaxin in groups. Eotaxin expression in control, AR-NS, AR-HRS and Normal-HRS groups was determined by
immuno cytochemistry. Immunoreactive eotaxin, detected using a Cy3-labeled secondary antibody (red), was highly expressed in nasal mucosa of
AR-NS group (c), and decreased in AR-HRS group (d). While in control subjects and normal-HRS subjects eosinophil infiltration was very scarce (a and b)
Fig. 9 Western blot analysis of eotaxin protein in groups. For the four groups: saline control, normal-HRS, AR- NS and AR-HRS. Western blot analysis
showed that the relative expression of eotaxin protein in the AR-NS group was much higher than that in control group, and decreased in AR–HRS group,
(*p< 0.05 versus control, #p< 0.05 versus AR-NS). No significance of protein expression were shown between control and Normal-NS groups (*p> 0.05)
Yu et al. Journal of Inflammation  (2017) 14:1 Page 10 of 12
eosinophil oxidative metabolism [36]. In the present
study, influence of HRS on eotaxin expression has also
been studied. Eotaxin, which is a CC Chemokine, was
originally isolated from the bronchoalveolar fluid of
allergic guinea pigs [37]. It has a strong chemotactic ac-
tivity that is specific for eosinophils, while it induced
monocyte chemotaxis only at a high concentration, and
did not induce neutrophil or lymphocyte chemotaxis at
all [38]. The eotaxin regulates eosinophil trafficking dur-
ing allergic inflammation and plays important role in
allergic reaction. As shown in the results, it is an in-
crease in ROS production with higher expressed eotaxin
in nasal mucosa of AR models, and it is also indicated
that ROS had an effect on the expression of eotaxin.
Therefore, the expression of eotaxin was also decreased
along with ROS production suppressed by HRS treat-
ment. It is implied that HRS also can suppress the
eotaxin expression and it may be related to a decrease in
ROS production in nasal mucosa of AR models.
Our study was the first to evaluate the molecular
hydrogen protects cells and tissues against oxidative
stress in AR models. It also raised the possibility of treat-
ing allergic respiratory diseases by using medical gas as
antioxidant therapy. Antioxidants gas, such as CO,H2S
and H2, will be a new treatment strategy in the therapy
of AR [39].
In conclusion, our data demonstrate that HRS attenu-
ates airway inflammation and suppresses the function
and counts of eosinophils in AR possibly through anti-
oxidation effect of hydrogen. However, more investiga-
tions should be carried out to identify the underlying
mechanisms in hydrogen-mediated anti-allergic in-
flammation in future. We also propose that molecular
hydrogen could be widely used in medical applica-
tions as a safe and effective protective drug with min-
imal side effects.
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